XHE - SPDR S&P Health Care Equipment ETF
| Assets | $772.29M |
| NAV | $121.62 |
| Expense Ratio | 0.35% |
| PE Ratio | 40.47 |
| Beta (5Y) | 0.96 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | Dec 23, 2019 |
| 1-Year Return | - |
| Trading Day | April 20 |
| Last Price | $120.81 |
| Previous Close | $121.56 |
| Change ($) | -0.75 |
| Change (%) | -0.62% |
| Day's Open | 121.32 |
| Day's Range | 119.97 - 121.99 |
| Day's Volume | 59,199 |
| 52-Week Range | 77.36 - 130.04 |
Fund Description
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the health care equipment and supplies segment of a U.S. total market composite index. In seeking to track the performance of the S&P Health Care Equipment Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the health care equipment segment of the S&P Total Market Index (S&P TMI).
| Asset Class Equity | Sector Healthcare |
| Region North America | Inception Date Jan 26, 2011 |
| Exchange NYSEARCA | Ticker Symbol XHE |
| Index Tracked S&P Health Care Equipment Select Industry Index | |
Top 10 Holdings
14.59% of assets| Name | Symbol | Weight |
|---|---|---|
| Novocure | NVCR | 1.66% |
| STAAR Surgical | STAA | 1.57% |
| GenMark Diagnostics | GNMK | 1.56% |
| ShockWave Medical | SWAV | 1.51% |
| Inogen | INGN | 1.46% |
| West Pharmaceutical Services | WST | 1.39% |
| Steris | STE | 1.36% |
| OrthoPediatrics | KIDS | 1.36% |
| Danaher | DHR | 1.36% |
| Neogen Corporation | NEOG | 1.36% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 23, 2019 | $0.003 | Dec 27, 2019 |
| Jun 24, 2019 | $0.02 | Jun 27, 2019 |
| Mar 18, 2019 | $0.024 | Mar 21, 2019 |
| Dec 24, 2018 | $0.045 | Dec 28, 2018 |
| Sep 24, 2018 | $0.02 | Sep 27, 2018 |
| Dec 15, 2017 | $0.4596 | Dec 26, 2017 |
Sector ETF report for XHE
How the presidential election could impact your portfolio
While most attention in health care has been going to large pharma companies, the charts suggest opportunities in niche subsectors.
Sector ETF report for XHE
Biotech stocks fall after Trump promises executive order drug prices
CNBC's Meg Tirrell reports on the dip in biotech stocks after President Donald Trump promised that an executive order on drug prices is coming.
Watch a CIO explain where investors can find value in the market amid trade tensions
Chris Zaccarelli, chief investment officer at Independent Advisor Alliance, joins "Squawk Box" to discuss where investors can find value in the markets as they continue to digest the news surrounding th...
These sectors came up with solid beat ratios in the fourth quarter earnings. This should benefit these ETFs.